Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.

The Possibility of Systematic Research Fraud Targeting Under-Studied Human Genes: Causes, Consequences, and Potential Solutions

Open access
Byrne, Jennifer A, Grima, Natalie, Capes-Davis, Amanda, Labbé, Cyril · 2019 · Biomarker Insights

Abstract

A major reason for biomarker failure is the selection of candidate biomarkers based on inaccurate or incorrect published results. Incorrect research results leading to the selection of unproductive biomarker candidates are largely considered to stem from unintentional research errors. The additional possibility that biomarker research may be actively misdirected by research fraud has been given comparatively little consideration. This review discusses what we believe to be a new threat to biomarker research, namely, the possible systematic production of fraudulent gene knockdown studies that target under-studied human genes. We describe how fraudulent papers may be produced in series by paper mills using what we have described as a ‘theme and variations’ model, which could also be considered a form of salami slicing. We describe features of these single-gene knockdown publications that may allow them to evade detection by journal editors, peer reviewers, and readers. We then propose a number of approaches to facilitate their detection, including improved awareness of the features of publications constructed in series, broader requirements to post submitted manuscripts to preprint servers, and the use of semi-automated literature screening tools. These approaches may collectively improve the detection of fraudulent studies that might otherwise impede future biomarker research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/1177271919829162

Cites

95 of 95 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Five phases of biomarker development, shown as the biomarker research pipeline, adapted from Pepe et al.9 The number of biomarker candidates within the pipeline (shown above the phase diagram) progressively reduces as candidate biomarkers are sequentially analysed, and a proportion of candidates are discarded. At the same time, the resources required to advance each candidate progressively increase (shown below the phase diagram). The selection of unproductive candidates at phase 1 may prevent more productive candidates from entering the pipeline.
Figure 1. Five phases of biomarker development, shown as the biomarker research pipeline, adapted from Pepe et al.9 The number of biomarker candidates within the pipeline (shown above the phase diagram) progressively reduces as candidate biomarkers are sequentially analysed, and a proportion of candidates are discarded. At the same time, the resources required to advance each candidate progressively increase (shown below the phase diagram). The selection of unproductive candidates at phase 1 may prevent more productive candidates from entering the pipeline.CC BY-NC · PubMed Central
Figure 2. Diagrammatic representation showing how the availability of research studies that support candidate genes can influence their selection to enter the biomarker research pipeline (phase 1, see Figure 1). Five genes (A-E) are shown. Genes A, B, D, and E are connected to functional studies (surrounding symbols) that support that gene as a candidate biomarker within a particular cancer type. Functional studies performed in different cancer types are shown as distinct symbols, with black symbols denoting bona fide published studies and purple symbols denoting fraudulent published studies. Without an understanding that genes B and E have been systematically targeted for the fraudulent production of manuscripts in series, genes B and E appear to be the best biomarker candidates and would be most likely to be selected for further biomarker studies. This decision could exclude genes A and D, which are supported by bona fide research, and which could in fact represent superior candidates.
Figure 2. Diagrammatic representation showing how the availability of research studies that support candidate genes can influence their selection to enter the biomarker research pipeline (phase 1, see Figure 1). Five genes (A-E) are shown. Genes A, B, D, and E are connected to functional studies (surrounding symbols) that support that gene as a candidate biomarker within a particular cancer type. Functional studies performed in different cancer types are shown as distinct symbols, with black symbols denoting bona fide published studies and purple symbols denoting fraudulent published studies. Without an understanding that genes B and E have been systematically targeted for the fraudulent production of manuscripts in series, genes B and E appear to be the best biomarker candidates and would be most likely to be selected for further biomarker studies. This decision could exclude genes A and D, which are supported by bona fide research, and which could in fact represent superior candidates.CC BY-NC · PubMed Central
Figure 3. Summary of the conserved series of experimental results shown in 5 TPD52L2 knockdown studies,37–41 4 of which have been retracted from the literature.37–40 The order of conserved figures is shown vertically and figure panels within each figure are shown horizontally. The data that were shown (upper panels) and the purpose of the experiments (lower panels) are described for each individual figure panel.
Figure 3. Summary of the conserved series of experimental results shown in 5 TPD52L2 knockdown studies,37–41 4 of which have been retracted from the literature.37–40 The order of conserved figures is shown vertically and figure panels within each figure are shown horizontally. The data that were shown (upper panels) and the purpose of the experiments (lower panels) are described for each individual figure panel.CC BY-NC · PubMed Central
Figure 4. Incorrectly identified short hairpin RNA (shRNA) sequences that were described in TPD52L2 knockdown studies37–41 and other single-gene knockdown publications.33 Nucleotide sequences are shown 5ʹ-3ʹ. Nucleotides that are identical to their indicated target according to blastn46 search results are underlined. (A) TPD52L2 shRNA, correctly used as a targeting sequence37,38,40,41 and incorrectly used as a non-targeting sequence.33,37,39 (B) NOB1 shRNA, incorrectly used as a non-targeting sequence.33,38,40
Figure 4. Incorrectly identified short hairpin RNA (shRNA) sequences that were described in TPD52L2 knockdown studies37–41 and other single-gene knockdown publications.33 Nucleotide sequences are shown 5ʹ-3ʹ. Nucleotides that are identical to their indicated target according to blastn46 search results are underlined. (A) TPD52L2 shRNA, correctly used as a targeting sequence37,38,40,41 and incorrectly used as a non-targeting sequence.33,37,39 (B) NOB1 shRNA, incorrectly used as a non-targeting sequence.33,38,40CC BY-NC · PubMed Central
Figure 5. Overview of the proposed key features of the construction of fraudulent manuscript series by paper mills using a ‘theme and variations’ approach. The ‘theme’ shown is an under-studied human gene which is examined in different cancer types to produce a number of manuscript ‘variations’. The existence of thousands of under-studied human genes means that this process could be repeated many times to produce large numbers of fraudulent manuscripts and ultimately publications.
Figure 5. Overview of the proposed key features of the construction of fraudulent manuscript series by paper mills using a ‘theme and variations’ approach. The ‘theme’ shown is an under-studied human gene which is examined in different cancer types to produce a number of manuscript ‘variations’. The existence of thousands of under-studied human genes means that this process could be repeated many times to produce large numbers of fraudulent manuscripts and ultimately publications.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

27 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

19 retracted

Show all 95 references

Research works printed but not linked: 12

  1. Retraction, 2016, Int J Clin Exp Med, 9, 12416
  2. Wang Z, 2014, Cell Mol Biol (Noisy-le-grand), 60, 39
  3. 10.1016/S0022-2836(05)80360-2 · doi:10.1016/s0022-2836(05)80360-2 · Paper page
  4. Huang WY, 2017, Asian Pac J Cancer Prev, 18, 2891
  5. 2017, Biomed Res Int, 2017, 3471417
  6. 2018, Int J Clin Exp Med, 11, 2917
  7. 2018, Int J Clin Exp Pathol, 11, 1838
  8. 2018, Int J Clin Exp Pathol, 11, 1836
  9. 2017, Asian Pac J Cancer Prev, 18, 2893
  10. 2017, Biomed Res Int, 2017, 7640820
  11. 2018, Int J Clin Exp Med, 11, 413
  12. Acuna DE, 2018, bioRxiv, 269415

Cited by

See all 35

Metadata

Authors
Byrne, J. A., Grima, N., Capes-Davis, A., & Labbé, C.
Affiliations
  • The University of Sydney (AU)
  • CellBank Australia, Children’s Medical Research Institute and The University of Sydney, Westmead, NSW, Australia
  • Institut polytechnique de Grenoble (FR)
Corresponding author
Byrne, Jennifer A
Venue
Biomarker Insights
Published
2019-01
Volume
14
Pages
1177271919829162-1177271919829162
ISSN
1177-2719 (ISSN-L)
OpenAlex
W2914992144
Cited by
34
References
95
Citations by year
2026: 4 · 2025: 1 · 2024: 8 · 2023: 4 · 2022: 4 · 2021: 6 · 2020: 7
FWCI
1.12
Type
journal article
Language
en
Open access
Licence
  • cc-by-nc
  • journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Biomarker Insights (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Post-Truth Initiative (SREI 2020)
  • US Office of Research Integrity Project Grant (ORIIR180038-01-00)
Topics
  • Social Sciences › Education › Academic integrity and plagiarism
  • Social Sciences › Library and Information Sciences › Academic Publishing and Open Access
  • Physical Sciences › Mathematics › Statistics and Probability › Benford’s Law and Fraud Detection
Keywords
scientific fraud, paper mills, salami slicing, fraud detection, preprint servers, peer review

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Possibility of Systematic Research Fraud Targeting Under-Studied Human Genes: Causes, Consequences, and Potential Solutions. https://app.cochat.ai/papers/10.1177/1177271919829162
The paper
Byrne, J. A., Grima, N., Capes-Davis, A., & Labbé, C. (2019). The Possibility of Systematic Research Fraud Targeting Under-Studied Human Genes: Causes, Consequences, and Potential Solutions. Biomarker Insights. https://doi.org/10.1177/1177271919829162

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.